UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study

The Lancet global health, 2023-08, Vol.11 (8), p.e1194-e1204

2023

Volltextzugriff (PDF)

Impact on Epidemic Measles of Vaccination Campaigns Triggered by Disease Outbreaks or Serosurveys: A Modeling Study

PLoS medicine, 2016-10, Vol.13 (10), p.e1002144-e1002144

2016

Volltextzugriff (PDF)

Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: Analysis of recent household surveys

Vaccine, 2020-03, Vol.38 (14), p.3062-3071

2020

Volltextzugriff (PDF)

Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination

The Journal of infectious diseases, 2018-07, Vol.218 (3), p.355-364

2018

Volltextzugriff (PDF)

Mapping the distribution of zero-dose children to assess the performance of vaccine delivery strategies and their relationships with measles incidence in Nigeria

Vaccine, 2023-01, Vol.41 (1), p.170-181

2023

Volltextzugriff (PDF)

Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries

eLife, 2021-06, Vol.10

2021

Volltextzugriff (PDF)

Measles elimination: progress, challenges and implications for rubella control

Expert review of vaccines, 2013-08, Vol.12 (8), p.917-932

2013

Volltextzugriff (PDF)

Immunogenicity of Standard-Titer Measles Vaccine in HIV-1-Infected and Uninfected Zambian Children: An Observational Study

The Journal of infectious diseases, 2007-08, Vol.196 (3), p.347-355

2007

Volltextzugriff (PDF)

Aerosol and subcutaneous measles vaccine: Measles antibody responses 6 years after re-vaccination

Vaccine, 2007-05, Vol.25 (21), p.4170-4174

2007

Volltextzugriff (PDF)

Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial

The Lancet (British edition), 2000-03, Vol.355 (9206), p.798-803

2000

Volltextzugriff (PDF)

Prospective Study of Measles in Hospitalized, Human Immunodeficiency Virus (HIV)—Infected and HIV—Uninfected Children in Zambia

Clinical infectious diseases, 2002-07, Vol.35 (2), p.189-196

2002

Volltextzugriff (PDF)

Implications of the Human Immunodeficiency Virus Epidemic for Control and Eradication of Measles

Clinical infectious diseases, 1999-07, Vol.29 (1), p.106-112

1999

Volltextzugriff (PDF)

Evaluating the impact of the HIV pandemic on measles control and elimination

Bulletin of the World Health Organization, 2005-05, Vol.83 (5), p.329-337

2005

Volltextzugriff (PDF)

Estimating the force of measles virus infection from hospitalised cases in Lusaka, Zambia

Vaccine, 2004-12, Vol.23 (6), p.732-738

2004

Volltextzugriff (PDF)

Measles vaccine effectiveness and risk factors for measles in Dhaka, Bangladesh

Bulletin of the World Health Organization, 2002-01, Vol.80 (10), p.776-782

2002

Volltextzugriff (PDF)

Persistence of measles antibody two years after revaccination by aerosol or subcutaneous routes

The Pediatric infectious disease journal, 2000-12, Vol.19 (12), p.1211-1213

2000

Volltextzugriff (PDF)

Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules

Vaccine, 2016-03, Vol.34 (12), p.1459-1464

2016

Volltextzugriff (PDF)

Evaluation of the Immune Response to a 2-Dose Measles Vaccination Schedule Administered at 6 and 9 Months of Age to HIV-Infected and HIV-Uninfected Children in Malawi

The Journal of infectious diseases, 2008-11, Vol.198 (10), p.1457-1465

2008

Volltextzugriff (PDF)

HIV-1 Infection in Zambian Children Impairs the Development and Avidity Maturation of Measles Virus–Specific Immunoglobulin G after Vaccination and Infection

The Journal of infectious diseases, 2009-10, Vol.200 (7), p.1031-1038

2009

Volltextzugriff (PDF)

Persistence of Vaccine-Induced Measles Antibody Beyond Age 12 Months: A Comparison of Response to One and Two Doses of Edmonston-Zagreb Measles Vaccine Among HIV-Infected and Uninfected Children in Malawi

The Journal of infectious diseases, 2011-07, Vol.204 (suppl_1), p.S149-S157

2011

Volltextzugriff (PDF)

Monitoring progress toward US preschool immunization goals

JAMA : the journal of the American Medical Association, 1992-04, Vol.267 (14), p.1952

1992

Volltextzugriff (PDF)

Comparison of a commercial enzyme immunoassay with plaque reduction neutralization for maternal and infant measles antibody measurement

Revista do Instituto de Medicina Tropical de São Paulo, 1999-01, Vol.41 (1), p.21-26

1999

Volltextzugriff (PDF)

Successes and failures in measles control

The Journal of infectious diseases, 1994-11, Vol.170 Suppl 1 (Supplement 1), p.S32-S41

1994

Volltextzugriff (PDF)

Rural Kenya: Measles during Pregnancy and Early Infancy

The Journal of infectious diseases, 2006-01, Vol.193 (1), p.165-166

2006

Volltextzugriff (PDF)

Measles control in young infants

The Lancet (British edition), 1993-05, Vol.341 (8853), p.1162-1162

Cutts, Felicity

1993

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

ThemaMeasles - Prevention & Control

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(31)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(31)
Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Measles
(26)
Infant
(25)
Vaccination
(19)
Child, Preschool
(18)
Infectious Diseases
(18)
Measles Vaccine - Administration & Dosage
(17)
Immunology
(16)
Biological And Medical Sciences
(15)
Child
(15)
Female
(15)
Medical Sciences
(15)
Measles - Epidemiology
(14)
Male
(13)
Vaccines
(13)
Antibodies, Viral - Blood
(11)
Immunization
(11)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study

Impact on Epidemic Measles of Vaccination Campaigns Triggered by Disease Outbreaks or Serosurveys: A Modeling Study

Geospatial variation in measles vaccine coverage through routine and campaign strategies in Nigeria: Analysis of recent household surveys

Benefits and Challenges in Using Seroprevalence Data to Inform Models for Measles and Rubella Elimination

Mapping the distribution of zero-dose children to assess the performance of vaccine delivery strategies and their relationships with measles incidence in Nigeria

Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries

Measles elimination: progress, challenges and implications for rubella control

Immunogenicity of Standard-Titer Measles Vaccine in HIV-1-Infected and Uninfected Zambian Children: An Observational Study

Aerosol and subcutaneous measles vaccine: Measles antibody responses 6 years after re-vaccination

Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial

Prospective Study of Measles in Hospitalized, Human Immunodeficiency Virus (HIV)—Infected and HIV—Uninfected Children in Zambia

Implications of the Human Immunodeficiency Virus Epidemic for Control and Eradication of Measles

Evaluating the impact of the HIV pandemic on measles control and elimination

Estimating the force of measles virus infection from hospitalised cases in Lusaka, Zambia

Measles vaccine effectiveness and risk factors for measles in Dhaka, Bangladesh

Persistence of measles antibody two years after revaccination by aerosol or subcutaneous routes

Supplemental measles vaccine antibody response among HIV-infected and -uninfected children in Malawi after 1- and 2-dose primary measles vaccination schedules

Evaluation of the Immune Response to a 2-Dose Measles Vaccination Schedule Administered at 6 and 9 Months of Age to HIV-Infected and HIV-Uninfected Children in Malawi

HIV-1 Infection in Zambian Children Impairs the Development and Avidity Maturation of Measles Virus–Specific Immunoglobulin G after Vaccination and Infection

Persistence of Vaccine-Induced Measles Antibody Beyond Age 12 Months: A Comparison of Response to One and Two Doses of Edmonston-Zagreb Measles Vaccine Among HIV-Infected and Uninfected Children in Malawi

Monitoring progress toward US preschool immunization goals

Comparison of a commercial enzyme immunoassay with plaque reduction neutralization for maternal and infant measles antibody measurement

Successes and failures in measles control

Rural Kenya: Measles during Pregnancy and Early Infancy

Measles control in young infants

Aktive Filter

Suchergebnisse filtern